Generally, these diseases involve aberrant or excessive activation of inflammatory responses such as occurs in autoimmune diseases or sepsis, and it is clear that the roles of ICAM-1 in adherence, transendothelial migration, and activation of leukocytes could render it both a causative factor in disease and an attractive therapeutic target. This evidence concerns the gene ICAM1 and Sepsis.